Skip to main content
. 2017 Oct 16;7:12756. doi: 10.1038/s41598-017-12934-y

Figure 1.

Figure 1

SRVF dramatically alters cell morphology and decreases cell viability in malignant cancer cells. (A) HT1080 cells were incubated with the indicated doses of SR, VF, or SRVF at concentrations of 50, 100, or 250 µg/ml for 24 h and photographed at a magnification of ×200 under an inverted microscope. (B) Cell viability after incubation with SR, VF, or SRVF was determined using the CCK assay and is expressed as the mean ± standard deviation (SD). (C) Cells were seeded onto the E-Plate 16, treated with SR, VF, or SRVF at a concentration of 250 µg/ml, and cell proliferation was monitored using the xCELLigence system. Data are representative of two independent experiments performed in triplicate and are expressed as the mean ± SD. (D,E) The effects of SR, VF, or SRVF on cell viability of MDA-MB231 (D) and HepG2 (E) cells were evaluated by the CCK assay and are expressed as the mean ± SD. Statistical significance was determined with Student’s t-test. *p < 0.05, **p < 0.05 vs. untreated control.